Angiotensin II receptors and angiotensin II receptor antagonists.
Du Pont Merck Pharmaceutical Company, Wilmington, Delaware 19880-0400.
P B
PB
Timmermans
P C
PC
Wong
A T
AT
Chiu
W F
WF
Herblin
P
P
Benfield
D J
DJ
Carini
R J
RJ
Lee
R R
RR
Wexler
J A
JA
Saye
R D
RD
Smith
D000595:Amino Acid Sequence; D000804:Angiotensin II / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000494:pharmacology; D057911:Angiotensin Receptor Antagonists; D000818:Animals; D000959:Antihypertensive Agents / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D003001:Cloning, Molecular; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007093:Imidazoles / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D007668:Kidney / Q000187:drug effects; D019808:Losartan; D008969:Molecular Sequence Data; D011725:Pyridines / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D011945:Receptors, Angiotensin / Q000737:chemistry / Q000502:physiology*; D013777:Tetrazoles / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D007093:Imidazoles; D011725:Pyridines; D011945:Receptors, Angiotensin; D013777:Tetrazoles; D000804:Angiotensin II; C066253:PD 123177; D019808:Losartan